In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Most type 2 diabetes patients are at high risk of a fatal heart attack or stroke

Diabetes and the Heart
Risk Factors and Prevention


Sophia Antipolis, 14 Nov 2020:  Preventing heart attacks and strokes in type 2 diabetes patients managed in primary care should be an urgent priority. That’s the conclusion of a study published on World Diabetes Day in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).1

“The most striking result of our study was that the vast majority of patients (93%) had a high or very high risk of fatal events within a decade. Half of patients in the very high-risk group had no history of heart disease, meaning they would not be receiving medications to prevent heart attacks and strokes,” said study author Dr. Manel Mata-Cases, a general practitioner for the Catalan Institute of Health in Sant Adrià de Besòs.2

“As far as we know, this study in nearly 375,000 people from a well-validated population-based database illustrates the situation in the Mediterranean for the first time. Traditionally, cardiovascular risk in the region has been lower than in central and northern Europe or the US; therefore, our results should generate concern and a call for action to prevent heart attacks and strokes in people with type 2 diabetes managed in primary care,” he added.

This was a cross-sectional study that used the Information System for the Development of Research in Primary Care (SIDIAP) database, which includes 74% of the total population in Catalonia, Spain. The SIDIAP database contains anonymous, longitudinal patient information extracted from the electronic medical record system (e-CAP) used by all primary health providers in Catalonia.

The study population consisted of 373,185 people aged 18 and over with a diagnosis of type 2 diabetes by 31 December 2016. The average age was 70.1 years and 45.2% were female. Some 72% had high blood pressure, 45% were obese, 60% had high serum cholesterol, and 14% were current smokers.

The investigators calculated the likelihood of each participant having a fatal heart attack or stroke within 10 years using categories in the ESC guidelines on diabetes and cardiovascular disease.3 The three categories are: very high risk (above 10%), high risk (between 5% and 10%), and moderate risk (below 5%).

To be classified as very high risk, patients must have established cardiovascular disease (e.g. prior heart attack or stroke), or other conditions which threaten their health such as kidney impairment, or at least three cardiovascular risk factors (older age, high blood pressure, high serum cholesterol, smoking, obesity).4

Over half of the participants (53.4%) were at very high risk of fatal events. This observation was more frequent in men (55.6%) than in women (50.7%). Some 39.6% were classified as high risk and just 7% had moderate risk of dying from a heart attack or stroke within 10 years.

Dr. Mata-Cases concluded: “These findings in a primary care setting should fuel the implementation of integrated care. Healthy behaviours are the cornerstone of preventing cardiovascular disease and need to be combined with control of blood glucose, serum cholesterol, and blood pressure. GPs and nurses should agree treatment objectives with patients considering their characteristics and preferences.”

Lifestyle advice for patients with diabetes

  • Quit smoking.
  • Reduce calorie intake to lower excessive body weight.
  • Adopt a Mediterranean diet supplemented with olive oil and/or nuts.
  • Avoid alcohol.
  • Do moderate-to-vigorous physical activity for at least 150 minutes per week.

 

ENDS

Notes to editor

Authors: ESC Press Office
Tel: +33 (0)4 89 87 20 85

Mobile: +33 (0)7 8531 2036
Email: press@escardio.org

Follow us on Twitter @ESCardioNews 

 

Funding: This study was supported by the Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol). CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM) is an initiative from Instituto de Salud Carlos III.

 

Disclosures: The authors declare that they have no conflict of interest associated with the contents of this manuscript.

 

References

1Cebrián-Cuenca A, Mata-Cases M, Franch-Nadal J, et al. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the 2019 ESC/EASD categories: data from a large Mediterranean population. Eur J Prev Cardiol. 2020. doi:10.1093/eurjpc/zwaa073.

2Dr. Mata-Cases is also a researcher at the Barcelona Ciutat Research Support Unit of the Foundation University Institute for Primary Health Care Research Jordi Gol i Gurina (IDIAPJGol) and the Centre of Investigation of Diabetes and Associated Metabolic Diseases (CIBERDEM) in Barcelona.

3Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255–323.

4The high risk category includes patients with established cardiovascular disease (e.g. prior heart attack or stroke). It also includes those with three or more cardiovascular risk factors (older age, high blood pressure, high blood cholesterol, smoking, obesity) or organ damage (proteinuria, kidney impairment, enlargement/thickening of the heart’s left ventricle, retinopathy).

 

About the European Journal of Preventive Cardiology
The European Journal of Preventive Cardiology is the world's leading preventive cardiology journal, playing a pivotal role in reducing the global burden of cardiovascular disease.

About the European Society of Cardiology

The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.